Ta-Chun Hang has worked in early development through commercial manufacturing for biologics and cell therapies, including supporting regulatory activities as well as heading pilot plant operations. He has combined his breadth of knowledge and expertise to drive innovation and novel approaches in process development. Ta-Chun completed two bachelor’s degrees (Biomedical Engineering, Human Physiology) from the University of Minnesota and a PhD in Biological Engineering from MIT.
Current role